MRMaria Rus

Maria Rus

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Rus has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Delia Muntean

    Multidisciplinary Research Center on Antimicrobial Resistance (MULTI-REZ), “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania

    2 shared publications
  • Florin George Horhat

    Department of Microbiology, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania

    2 shared publications
  • Monica Licker

    Multidisciplinary Research Center on Antimicrobial Resistance (MULTI-REZ), “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania

    2 shared publications
  • Natalia Cirlea

    “Pius Brinzeu” County Clinical Emergency Hospital, Timisoara, Romania

    2 shared publications
  • Alin Adrian Cumpanas

    Department of Orthopaedics - Traumatology, Urology and Medical Imaging, "Victor BabesŞ" University of Medicine and Pharmacy, TimisŞoara, Romania

    1 shared publication
  • Alina Tamas

    “Pius Brinzeu” County Clinical Emergency Hospital, Timisoara, Romania

    1 shared publication

Latest Publications

  • Open Access

    Distribution of NDM1 Carbapenemase-Producing Proteeae Strains on High-Risk Hospital Wards

    by Maria Rus, Monica Licker, Corina Musuroi, Edward Seclaman, Delia Muntean, Natalia Cirlea, Alina Tamas, Silvana Vulpie, Florin George Horhat, Luminita Baditoiu

    Background: Carbapenem-resistant Proteeae (CRP) is a group of multidrug-resistant (MDR) microorganisms that raise special treatment problems due to their intrinsic resistance to colistin. In this study, our aim is to provide a phenotypic and molecular characterization of the carbapenemases secreted by CRP strains isolated from inpatients from an intensive care unit (ICU) and surgical wards, as well as the identification of the risk factors involved in their acquisition. Methods: An observational, cross-sectional study was performed which included all Proteeae strains isolated in samples from inpatients on high-risk wards of the largest university hospital in Western Romania, from July 2017 to April 2019. Meropenemresistant strains (N=65) with MIC >= 16 mu g/mL were subjected to a singleplex PCR assay for the detection of blaNDM, blaVIM and blaCTX-M genes. The analysis of risk factors was performed by logistic regression. Results: Out of 8317 samples that were processed, 400 Proteeae strains were isolated: 64% belonging to the genus Proteus, 26.75% to the genus Providencia and 9.25% to the genus Morganella. Most CRP strains (N=56) were of MBL type, and 55 had the blaNDM gene as the prevalent gene substrate. P. stuartii was the main species that provided the circulating MDR strains. Most CRP strains came from patients admitted to ICU, being isolated mainly from bronchial aspirates and blood cultures. Multivariate analysis revealed 3 independent risk factors - mechanical ventilation>96h (HR: 40.51 [13.65-120.25], p <0.001), tracheostomy (HR: 2.65 [1.14-6.17], p = 0.024) and prolonged antibiotic therapy (HR: 1.01 [1.00-1.02], p = 0.03). Conclusion: There is a significant increase in the incidence of CR P. stuartii strains, the MBL-blaNDM type being predominant. These strains presented various other resistance mechanisms, being often extremely difficult to treat and led to an excess of lethality of 27.16%.


  • Open Access

    Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

    by Monica Licker, Teodora Sorescu, Maria Rus, Natalia Cirlea, Florin Horhat, Cristiana Jurescu, Mircea Botoca, Alin Adrian Cumpanas, Romulus Timar, Delia Muntean

    Purpose: We report an outbreak of urinary tract infections (UTIs) caused by Myroides odoratimimus, which occurred in the largest clinical hospital in western Romania. Patients and methods: From June to August 2017, four strains of M. odoratimimus were isolated from the urine samples of patients hospitalized in the urology, diabetes, and surgery departments. Hospital records of all patients whose urine cultures were positive for M. ­odoratimimus were reviewed retrospectively. We also reviewed the cases reported in the literature. Results: All UTIs, except one, were hospital-acquired infections. All patients with M. odoratimimus UTIs were immunocompromised. Three patients underwent urinary catheterization with a Foley’s catheter upon admission in the emergency department and one presented for replacement of ureterostomy tubes. All Myroides isolates were resistant to almost all the tested antibiotics. Two patients were successfully treated with tigecycline and one was receiving antimicrobial treatment for another infection at the time of isolation of the microorganism. Conclusion: Although M. odoratimimus is an uncommon pathogen, clinicians should be aware of its ability to cause UTI outbreaks, especially in the immunocompromised population. Due to its multi-drug resistance, it is important to rapidly identify Myroides spp. in order to choose the best treatment regimen.